GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » EV-to-Revenue

Shandong Boan Biotechnology Co (HKSE:06955) EV-to-Revenue : 8.01 (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shandong Boan Biotechnology Co's enterprise value is HK$5,415.4 Mil. Shandong Boan Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$676.1 Mil. Therefore, Shandong Boan Biotechnology Co's EV-to-Revenue for today is 8.01.

The historical rank and industry rank for Shandong Boan Biotechnology Co's EV-to-Revenue or its related term are showing as below:

HKSE:06955' s EV-to-Revenue Range Over the Past 10 Years
Min: 7.8   Med: 13.27   Max: 49.69
Current: 8.01

During the past 4 years, the highest EV-to-Revenue of Shandong Boan Biotechnology Co was 49.69. The lowest was 7.80. And the median was 13.27.

HKSE:06955's EV-to-Revenue is ranked better than
51.01% of 1039 companies
in the Biotechnology industry
Industry Median: 8.37 vs HKSE:06955: 8.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), Shandong Boan Biotechnology Co's stock price is HK$10.20. Shandong Boan Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.33. Therefore, Shandong Boan Biotechnology Co's PS Ratio for today is 7.68.


Shandong Boan Biotechnology Co EV-to-Revenue Historical Data

The historical data trend for Shandong Boan Biotechnology Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co EV-to-Revenue Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - 17.63 12.01

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - 17.63 - 12.01

Competitive Comparison of Shandong Boan Biotechnology Co's EV-to-Revenue

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Boan Biotechnology Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's EV-to-Revenue falls into.



Shandong Boan Biotechnology Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shandong Boan Biotechnology Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=5415.378/676.096
=8.01

Shandong Boan Biotechnology Co's current Enterprise Value is HK$5,415.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shandong Boan Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$676.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Boan Biotechnology Co  (HKSE:06955) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shandong Boan Biotechnology Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=10.20/1.328
=7.68

Shandong Boan Biotechnology Co's share price for today is HK$10.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.33.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Boan Biotechnology Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Traded in Other Exchanges
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines